TITLE

Controlling the complications of diabetes: It's about the sugar

AUTHOR(S)
Flegel, Ken
PUB. DATE
September 2009
SOURCE
CMAJ: Canadian Medical Association Journal;9/15/2009, Vol. 181 Issue 6/7, p357
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a reprint of the article "Controlling the Complications of Diabetes: It's About the Sugar," which appeared at www.cmaj.ca. It reflects on the debate whether glucose control is a critical factor to prevent the complications of type 2 diabetes mellitus. However, evidences showed that tight control of glucose levels has been clearly established in type 1 diabetes. He implies that to end this debate is continue learning how best to achieve this therapeutics safely.
ACCESSION #
44132474

 

Related Articles

  • Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects. Luna, V.; Casauban, L.; Sajan, M.; Gomez-Daspet, J.; Powe, J.; Miura, A.; Rivas, J.; Standaert, M.; Farese, R. // Diabetologia;Feb2006, Vol. 49 Issue 2, p375 

    Aims/hypothesis: Metformin is widely used for treating type 2 diabetes mellitus, but its actions are poorly understood. In addition to diminishing hepatic glucose output, metformin, in muscle, activates 5′-AMP-activated protein kinase (AMPK), which alone increases glucose uptake and...

  • EVALUATION OF THE FINNISH DIABETES RISK SCORE (FINDRISC) FOR DIABETES SCREENING IN OCCUPATIONAL HEALTH CARE. MAURICE VANDERSMISSEN, GODELIEVE JOHANNA; GODDERIS, LODE // International Journal of Occupational Medicine & Environmental H;2015, Vol. 28 Issue 3, p587 

    Objectives: The objective of the study was to investigate the prevalence of undiagnosed dysglycaemia and the risk for type 2 diabetes using the Finnish Diabetes Risk Score (FINDRISC) in the working population of Belgium. Moreover, it was to evaluate performance and applicability of FINDRISC as a...

  • Revisiting screening for type 2 diabetes mellitus: the case for and against using HbA1c. Hanna, Fahmy W. F.; Wilkie, Veronica; Issa, Basil G.; Fryer, Anthony A. // British Journal of General Practice;Apr2015, Vol. 65 Issue 633, pe278 

    The article focuses on the advantages of early detection of type 2 diabetes mellitus to reduce the incidence rate of complications in Great Britain. Topics include the growing number of morbidity and premature mortality caused by type 2 diabetes mellitus, the use of oral glucose tolerance test...

  • DPP-4 Inhibitors as a New Option for the Management of Type 2 Diabetes. Sang Ah Lee // Journal of Korean Diabetes;2013, Vol. 14 Issue 3, p128 

    Dipeptidylpeptidase-4 (DPP-4) inhibitors are new glucose-lowering agents with mechanisms that differ from those of previous oral hypoglycemic agents (OHAs). DPP-4 inhibitors have shown a continuous glucose lowering effect (> 0.5%) when used in monotherapy as well as when used in combination with...

  • Inhibition of SGLT2: A Novel Strategy for Treatment of Type 2 Diabetes Mellitus. Pfister, M.; Whaley, J. M.; Zhang, L.; List, J. F. // Clinical Pharmacology & Therapeutics;Apr2011, Vol. 89 Issue 4, p621 

    The article focuses on the therapeutic use of selective inhibition of sodium-glucose cotransporter 2 (SGLT2) on type 2 diabetes mellitus (T2DM). It discusses the critical roles of SGLT1in the absorption of glucose and galactose and SGLT2 in the mediation of renal glucose reabsorption. Several...

  • Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. Mohamadshahi, Majid; Veissi, Masoud; Haidari, Fatemeh; Shahbazian, Hajieh; Kaydani, Gholam-Abas; Mohammadi, Fatemeh // BioImpacts;2014, Vol. 4 Issue 2, p83 

    Introduction: The role of inflammatory cytokines in diabetes and its complications has been shown in some studies. The purpose of this study was to compare the effect of probiotic and conventional yogurt on inflammatory markers in patients with type 2 diabetes. Methods: Forty-four patients with...

  • Preventing CVD in Adults with Type 2 Diabetes Mellitus: An Update from the AHA and ADA. HAUK, LISA // American Family Physician;2/1/2016, Vol. 93 Issue 3, p232 

    The article presents an update from the American Heart Association (AHA) and American Diabetes Association (ADA) regarding the prevention of cardiovascular disease (CVD) among adults with type II diabetes mellitus. Information provided include the use of angiotensin-converting enzyme inhibitor...

  • Ginger, Plant Compounds May Delay Diabetic Complications.  // Nutraceuticals World;Nov2015, Vol. 18 Issue 9, p57 

    The article discusses the study conducted by Shengmin Sang of the North Carolina Agricultural and Technical State University (NCA&T) which found that plant compounds such as ginger could delay diabetic complications and could treat type 2 diabetes. The study suggests that ginger and other plant...

  • Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas. Scott, A.R.; Attenborough, Y.; Peacock, I.; Fletcher, E.; Jeffcoate, W.J.; Tattersall, R.B. // BMJ: British Medical Journal (International Edition);9/17/88, Vol. 297 Issue 6650, p707 

    Explores the efficacy of managements for non-insulin-dependent diabetes. Administration of high fiber diet, basal insulin supplements and a regimen of insulin for diabetics; Absence of changes in hemoglobin A[sub 1] concentration during high fiber diet; Improvement of control of diabetes by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics